Skip to main content

Table 1 Pretreatment characteristics of the sample

From: Changes in salivary oxidative status, salivary cortisol, and clinical symptoms in female patients with temporomandibular disorders during occlusal splint therapy: a 3-month follow up

Variable

completed (n = 12)

dropped out (n = 3)

mean (SD)

(95% CI)

mean (SD)

(95% CI)

Maximal comfortable mouth opening (mm)

28.00 (10.81)

21.13–34.86

31.66 (20.21)

−18.53 - 81.86

OHIP-14

28.22 (6.06)

24.47–32.18

19.66 (6.02)

4.69–34.63

PSS

16.91 (6.78)

12.60–21.22

19.33 (2.08)

14.16–24.50

VAS

70.00 (20.33)

51.51–84.83

50.00 (10.00)

25.15–74.84

CPI

51.07 (18.77)

39.14–63.01

39.33 (17.01)

− 2.29 - 81.58

PHQ-15

6.25 (3.04)

4.31–8.18

11.00 (3.61)

2.04–19.95

PHQ-9

5.00 (4.31)

2.26–7.73

8.00 (5.56)

−5.83 - 21.83

GAD-7

5.58 (5.05)

2.37–8.79

7.33 (5.85)

−7.22 - 21.88

OBC

25.16 (11.06)

18.13–32.19

33.33 (9.86)

8.82–57.84

  1. PSS Perceived Stress Scale, VAS Visual Analogue Scale, OHIP-14 Oral Health Impact Profile
  2. CPI Characteristic pain intensity: low intensity pain < 50; high intensity pain ≥50
  3. PHQ-15 physical symptoms: scores of 5, 10, and 15 represent cut-points for low, medium, and high physical symptoms, respectively
  4. PHQ-9 depression: scores of 5, 10, 15, and 20 represent cut-points for mild, moderate, moderately severe, and severe depression
  5. GAD-7 anxiety: scores of 5, 10, and 15 represent cut-points for mild, moderate, and severe anxiety
  6. OBC oral behaviors checklist: 0–16 -represents normal behaviors; 17–24 - occurs twice as often in TMD patients; 25–62- risk for TMD